Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is March 15, 2025 Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2025, Vol. 30 ›› Issue (2): 171-182.doi: 10.12092/j.issn.1009-2501.2025.02.003

Previous Articles     Next Articles

Current status and progress of targeted therapy for hepatocellular carcinoma

CHEN Zhiwen, WANG Longrong, WANG Lu   

  1. Department of Hepatic Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China
  • Received:2024-08-05 Revised:2024-12-03 Online:2025-02-26 Published:2025-02-05

Abstract:

Hepatocellular carcinoma, as a common malignant tumor, remains a serious global health problem. Traditional methods such as surgical resection and chemotherapy have limited effects in improving the prognosis of advanced hepatocellular carcinoma. With the deepening of research into molecular mechanisms, targeted therapy has become an important direction for the treatment of hepatocellular carcinoma. In this review, we summarize the main targeted drugs and associated therapeutic strategies for hepatocellular carcinoma, aiming to provide references and evidence for future related research.

Key words: hepatocellular carcinoma, targeted therapies, immunotherapy, combination therapy

CLC Number: